[HTML][HTML] Review of COVID-19 testing and diagnostic methods

O Filchakova, D Dossym, A Ilyas, T Kuanysheva… - Talanta, 2022 - Elsevier
More than six billion tests for COVID-19 has been already performed in the world. The
testing for SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) virus and …

Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection

J Dinnes, P Sharma, S Berhane… - Cochrane database …, 2022 - cochranelibrary.com
Background Accurate rapid diagnostic tests for SARS‐CoV‐2 infection would be a useful
tool to help manage the COVID‐19 pandemic. Testing strategies that use rapid antigen tests …

Photocontrolled crRNA activation enables robust CRISPR-Cas12a diagnostics

M Hu, Z Qiu, Z Bi, T Tian, Y Jiang… - Proceedings of the …, 2022 - National Acad Sciences
CRISPR diagnostics based on nucleic acid amplification faces barriers to its commercial
use, such as contamination risks and insufficient sensitivity. Here, we propose a robust …

Simultaneous dual‐gene diagnosis of SARS‐CoV‐2 based on CRISPR/Cas9‐mediated lateral flow assay

E Xiong, L Jiang, T Tian, M Hu, H Yue… - Angewandte Chemie …, 2021 - Wiley Online Library
Few methods for the detection of SARS‐CoV‐2 currently have the capability to
simultaneously detect two genes in a single test, which is a key measure to improve …

Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example

T Kang, J Lu, T Yu, Y Long, G Liu - Biosensors and Bioelectronics, 2022 - Elsevier
Achieving superhigh sensitivity is the ultimate goal for bio-detection in modern analytical
science and life science. Among variable signal amplification strategies, nucleic acid …

The CRISPR–Cas toolbox for analytical and diagnostic assay development

Y Tang, L Gao, W Feng, C Guo, Q Yang, F Li… - Chemical Society …, 2021 - pubs.rsc.org
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-
associated (Cas) systems have revolutionized biological and biomedical sciences in many …

CRISPR-Cas based virus detection: Recent advances and perspectives

L Yin, S Man, S Ye, G Liu, L Ma - Biosensors and Bioelectronics, 2021 - Elsevier
Viral infections are one of the most intimidating threats to human beings. One convincing
example is the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2. Rapid …

CRISPR‐Cas biochemistry and CRISPR‐based molecular diagnostics

Z Weng, Z You, J Yang, N Mohammad… - Angewandte Chemie …, 2023 - Wiley Online Library
Polymerase chain reaction (PCR)‐based nucleic acid testing has played a critical role in
disease diagnostics, pathogen surveillance, and many more. However, this method requires …

A microfluidic-integrated lateral flow recombinase polymerase amplification (MI-IF-RPA) assay for rapid COVID-19 detection

D Liu, H Shen, Y Zhang, D Shen, M Zhu, Y Song… - Lab on a Chip, 2021 - pubs.rsc.org
The COVID-19 pandemic, caused by SARS-CoV-2, currently poses an urgent global
medical crisis for which there remains a lack of affordable point-of-care testing (POCT). In …

Detection of SARS-CoV-2 by CRISPR/Cas12a-enhanced colorimetry

Y Jiang, M Hu, AA Liu, Y Lin, L Liu, B Yu, X Zhou… - ACS …, 2021 - ACS Publications
The outbreak of COVID-19 caused a worldwide public health crisis. Large-scale population
screening is an effective means to control the spread of COVID-19. Reverse transcription …